The objective of this study is to provide the European Commission with current information on the diagnostic nuclear medicine market in the EU, focusing on the market of Mo-99/Tc-99m generators. The main purpose is to assess the reimbursement at end-user level and to quantify the financial resources dedicated to the purchase cost of the radionuclide Tc-99m.

Gathering of data to specify the medical indications and to quantify the number and reimbursement of diagnostic procedures using the radionuclide Tc-99m in all Member States of the European Union.

Evaluation of the data.